• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

营养不良的结直肠癌患者的粪便会加速癌症进展。

Faeces from malnourished colorectal cancer patients accelerate cancer progression.

作者信息

Chao Xu, Lei Zhang, Hongqin Liu, Ziwei Wang, Dechuan Li, Weidong Du, Lu Xu, Haitao Chen, Bo Zhang, Haixing Ju, Qinghua Yao

机构信息

Department of Integrated Chinese and Western Medicine, Cancer Hospital of the University of Chinese Academy of Sciences (CHUCAS, Zhejiang Cancer Hospital), Hangzhou, 310022, China.

Department of Thoracic Surgery, Cancer Hospital of the University of Chinese Academy of Sciences (CHUCAS, Zhejiang Cancer Hospital), Hangzhou, 310022, China.

出版信息

Clin Nutr. 2022 Mar;41(3):632-644. doi: 10.1016/j.clnu.2022.01.001. Epub 2022 Jan 10.

DOI:10.1016/j.clnu.2022.01.001
PMID:35124471
Abstract

BACKGROUD

Malnutrition has been confirmed to play an important role in colorectal cancer (CRC) progression via the gut microenvironment. However, the characteristics of the gut microbiota or its potential biological mechanism in CRC remain inconclusive.

METHODS

In this work, Patient-Generated Subjective Global Assessment (PG-SGA) tool and 16sRNA sequencing were prepared to detect the variation in gut microbiota and the association between nutrition status and gut microbiota. RDA/CCA analysis was used to evaluate the relationship between faecal microbiota from malnourished CRC and clinical nutrition indicators. To investigate the mechanism of the gut microbiota in CRC, faecal samples from malnourished CRC patients were transplanted into C57BL/6J and DSS/AOM mouse models. Moreover, FACS and IHC were prepared to detect the infiltration of B cells and macrophages. qPCR and Elisa assays were performed to explore the expression of cytokines.

RESULT

We found dramatic variation in the faecal microbiota among patients with different nutritional statuses, discovering that specific microbiota species, namely, Atopobium vaginae, Selenomonas sputigena and Faecalibacterium prausnitzii, may be considered diagnostic biomarkers in malnutrition and indicate poor prognosis. High expression level of A. vaginae in CRC tissues revealed the poorer overall survival compared with low expression level (Mean survival: 23.0 months vs 29.0 months). Faecal from malnourished colorectal cancer were found to be protumorigenic. More importantly, our evidence suggests that after faecal microbiota transplantation, B cells and macrophages are recruited to activate specific tumour immunity in CRC. Depletion of B cells significantly suppressed faecal microbiota-induced M2b polarization as well as the protumorigenic activity of tumour-associated macrophages in vivo.

CONCLUSION

Faecal microbiota in CRC under malnutrition conditions exhibits specific characteristics that accelerate CRC progression and regulate B cells and macrophages. The use of specific faecal microbial species could be a feasible approach for identifying the malnutrition status of patients and demonstrating the poor prognosis of CRC.

摘要

背景

营养不良已被证实在通过肠道微环境促进结直肠癌(CRC)进展中发挥重要作用。然而,CRC中肠道微生物群的特征或其潜在生物学机制仍无定论。

方法

在本研究中,采用患者主观整体评定法(PG-SGA)工具和16sRNA测序来检测肠道微生物群的变化以及营养状况与肠道微生物群之间的关联。利用冗余分析/典范对应分析(RDA/CCA)评估营养不良CRC患者粪便微生物群与临床营养指标之间的关系。为了探究肠道微生物群在CRC中的作用机制,将营养不良CRC患者的粪便样本移植到C57BL/6J和葡聚糖硫酸钠/氧化偶氮甲烷(DSS/AOM)小鼠模型中。此外,采用荧光激活细胞分选术(FACS)和免疫组化(IHC)检测B细胞和巨噬细胞的浸润情况。通过实时定量聚合酶链反应(qPCR)和酶联免疫吸附测定(ELISA)检测细胞因子的表达。

结果

我们发现不同营养状况患者的粪便微生物群存在显著差异,发现特定的微生物种类,即阴道阿托波菌、生痰月形单胞菌和普拉梭菌,可能被视为营养不良的诊断生物标志物,并预示预后不良。CRC组织中阴道阿托波菌的高表达水平显示与低表达水平相比总体生存率更低(平均生存期:23.0个月对29.0个月)。发现营养不良结直肠癌患者的粪便具有促肿瘤作用。更重要的是,我们的证据表明,粪便微生物群移植后,B细胞和巨噬细胞被募集以激活CRC中的特异性肿瘤免疫。B细胞的耗竭显著抑制了粪便微生物群诱导的M2b极化以及体内肿瘤相关巨噬细胞的促肿瘤活性。

结论

营养不良条件下CRC中的粪便微生物群表现出加速CRC进展并调节B细胞和巨噬细胞的特定特征。使用特定的粪便微生物种类可能是识别患者营养不良状态并证明CRC预后不良的一种可行方法。

相似文献

1
Faeces from malnourished colorectal cancer patients accelerate cancer progression.营养不良的结直肠癌患者的粪便会加速癌症进展。
Clin Nutr. 2022 Mar;41(3):632-644. doi: 10.1016/j.clnu.2022.01.001. Epub 2022 Jan 10.
2
Pectin supplement significantly enhanced the anti-PD-1 efficacy in tumor-bearing mice humanized with gut microbiota from patients with colorectal cancer.果胶补充剂显著增强了用来自结直肠癌患者的肠道微生物群人源化的荷瘤小鼠的抗PD-1疗效。
Theranostics. 2021 Feb 19;11(9):4155-4170. doi: 10.7150/thno.54476. eCollection 2021.
3
Gut microbiota-stimulated cathepsin K secretion mediates TLR4-dependent M2 macrophage polarization and promotes tumor metastasis in colorectal cancer.肠道微生物群刺激组织蛋白酶 K 的分泌,介导 TLR4 依赖性 M2 巨噬细胞极化,并促进结直肠癌的肿瘤转移。
Cell Death Differ. 2019 Nov;26(11):2447-2463. doi: 10.1038/s41418-019-0312-y. Epub 2019 Mar 8.
4
Gut microbiota drives colon cancer risk associated with diet: a comparative analysis of meat-based and pesco-vegetarian diets.肠道微生物群驱动与饮食相关的结肠癌风险:基于肉类和鱼素食的比较分析。
Microbiome. 2024 Sep 27;12(1):180. doi: 10.1186/s40168-024-01900-2.
5
Heart failure-induced microbial dysbiosis contributes to colonic tumour formation in mice.心力衰竭引起的微生物失调导致小鼠结肠肿瘤的形成。
Cardiovasc Res. 2024 May 7;120(6):612-622. doi: 10.1093/cvr/cvae038.
6
Inhibition of the NF-κB/HIF-1α signaling pathway in colorectal cancer by tyrosol: a gut microbiota-derived metabolite.色氨酸通过 NF-κB/HIF-1α 信号通路抑制结直肠癌细胞:一种肠道微生物衍生代谢物。
J Immunother Cancer. 2024 Sep 28;12(9):e008831. doi: 10.1136/jitc-2024-008831.
7
Metformin Regulates Gut Microbiota Abundance to Suppress M2 Skewing of Macrophages and Colorectal Tumorigenesis in Mice.二甲双胍通过调节肠道微生物群落丰度来抑制 M2 型巨噬细胞极化并抑制小鼠结直肠肿瘤发生。
J Microbiol. 2023 Jan;61(1):109-120. doi: 10.1007/s12275-022-00010-8. Epub 2023 Jan 26.
8
Diagnostic test accuracy of nutritional tools used to identify undernutrition in patients with colorectal cancer: a systematic review.用于识别结直肠癌患者营养不良的营养评估工具的诊断测试准确性:一项系统综述
JBI Database System Rev Implement Rep. 2015 May 15;13(4):141-87. doi: 10.11124/jbisrir-2015-1673.
9
Reduced rotavirus vaccine efficacy in protein malnourished human-faecal-microbiota-transplanted gnotobiotic pig model is in part attributed to the gut microbiota.在蛋白质营养不良的人源粪菌移植无菌猪模型中,轮状病毒疫苗效力降低部分归因于肠道微生物群。
Benef Microbes. 2020 Dec 2;11(8):733-751. doi: 10.3920/BM2019.0139. Epub 2020 Nov 27.
10
Using gut microbiota as a diagnostic tool for colorectal cancer: machine learning techniques reveal promising results.利用肠道微生物群作为结直肠癌的诊断工具:机器学习技术显示出有希望的结果。
J Med Microbiol. 2023 Jun;72(6). doi: 10.1099/jmm.0.001699.

引用本文的文献

1
Changes in fecal bacterial and fungal diversity, blood short chain fatty acids, and metabolomics in stage IV colorectal cancer patients.IV期结直肠癌患者粪便细菌和真菌多样性、血液短链脂肪酸及代谢组学的变化
Medicine (Baltimore). 2025 Sep 5;104(36):e44102. doi: 10.1097/MD.0000000000044102.
2
The role of intestinal macrophage polarization in colitis-associated colon cancer.肠道巨噬细胞极化在结肠炎相关结肠癌中的作用。
Front Immunol. 2025 Mar 5;16:1537631. doi: 10.3389/fimmu.2025.1537631. eCollection 2025.
3
Meta-analysis of postoperative incision infection risk factors in colorectal cancer surgery.
结直肠癌手术术后切口感染危险因素的Meta分析
Front Surg. 2024 Aug 13;11:1415357. doi: 10.3389/fsurg.2024.1415357. eCollection 2024.
4
Role of dietary nutrients and metabolism in colorectal cancer.膳食营养素与代谢在结直肠癌中的作用。
Asia Pac J Clin Nutr. 2024 Jun;33(2):153-161. doi: 10.6133/apjcn.202406_33(2).0002.
5
Gut microbiota and tumor-associated macrophages: potential in tumor diagnosis and treatment.肠道微生物群与肿瘤相关巨噬细胞:在肿瘤诊断和治疗中的潜力。
Gut Microbes. 2023 Dec;15(2):2276314. doi: 10.1080/19490976.2023.2276314. Epub 2023 Nov 9.
6
Murine models of colorectal cancer: the azoxymethane (AOM)/dextran sulfate sodium (DSS) model of colitis-associated cancer.结直肠癌的鼠类模型:葡聚糖硫酸钠(DSS)/氧化偶氮甲烷(AOM)诱导的结肠炎相关结肠癌模型。
PeerJ. 2023 Oct 31;11:e16159. doi: 10.7717/peerj.16159. eCollection 2023.
7
Selenomonas sputigena acts as a pathobiont mediating spatial structure and biofilm virulence in early childhood caries.唾液链球菌(Selenomonas sputigena)作为一种条件致病菌,介导婴幼儿龋病的空间结构和生物膜毒力。
Nat Commun. 2023 May 22;14(1):2919. doi: 10.1038/s41467-023-38346-3.
8
Surgical Prehabilitation in Patients with Gastrointestinal Cancers: Impact of Unimodal and Multimodal Programs on Postoperative Outcomes and Prospects for New Therapeutic Strategies-A Systematic Review.胃肠道癌患者的手术前康复治疗:单模式和多模式方案对术后结局的影响及新治疗策略的前景——一项系统评价
Cancers (Basel). 2023 Mar 21;15(6):1881. doi: 10.3390/cancers15061881.
9
The crosstalk between the gut microbiota and tumor immunity: Implications for cancer progression and treatment outcomes.肠道微生物群与肿瘤免疫的串扰:对癌症进展和治疗结果的影响。
Front Immunol. 2023 Jan 16;13:1096551. doi: 10.3389/fimmu.2022.1096551. eCollection 2022.
10
A Novel Inflammatory and Nutritional Prognostic Scoring System for Nonpathological Complete Response Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy.一种用于新辅助化疗的非病理性完全缓解乳腺癌患者的新型炎症和营养预后评分系统。
Dis Markers. 2022 Dec 16;2022:8044550. doi: 10.1155/2022/8044550. eCollection 2022.